文献速递乳腺乳腺X线

连续五年数字乳腺断层合成筛查:按筛查年份与轮次的结果

Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.
PubMed 文献 · Radiology · 2020-03-10

回顾性分析2011年9月至2016年9月共67 350次检查(29 310名女性),比较1年数字乳腺摄影(DM)与5年数字乳腺断层合成(DBT)筛查结果。DBT组召回率显著低于DM组(8.0% vs 10.4%,P < .001),癌检出率两组差异无统计学意义(6.0/1000 vs 5.1/1000,P = .25);调整分析中DBT的召回率、活检推荐率及召回阳性预测值均改善(P ≤ .001)。DBT筛查的有利结果在多个年份和轮次中持续存在。

要点

  • DBT组召回率8.0%显著低于DM组10.4%(P < .001),癌检出率6.0/1000 vs 5.1/1000差异无统计学意义(P = .25)。
  • 调整分析中DBT较DM的召回率、活检推荐率及召回阳性预测值均改善(P ≤ .001)。
  • DBT检出癌中浸润性癌占比70%(238/340)vs DM 68.5%(37/54),不良预后特征占比32.6%(76/233)vs 25.0%(9/36)。

核心结论

  • DBT筛查的有利结果在多个年份和轮次中持续存在,且DBT筛查检出的不良预后癌比例高于DM。

研究设计与样本

  • 回顾性分析纳入2011年9月至2016年9月共67 350次检查、29 310名女性,包括1年DM和5年DBT筛查。
  • DBT检查56 839次,DM检查10 511次;全队列平均年龄56岁±11,DBT组55岁±11,DM组57岁±11。
  • 通过链接州癌症登记处捕获筛查后1年内诊断的癌症,并按预后因素对生物学特征分组。
  • 采用logistic回归比较DBT各轮次与DM轮次的表现趋势,并校正年龄、种族、乳腺密度、基线检查和阅片者。

诊断标准与关键数值

  • 召回率DBT组8.0%(4522/56 839,95%CI:7.7,8.2)显著低于DM组10.4%(1094/10 511,95%CI:9.8,11.0)(P < .001)。
  • 癌检出率DBT组6.0/1000(95%CI:5.4,6.7;340/56 839)高于DM组5.1/1000(95%CI:3.9,6.6;54/10 511),但差异无统计学意义(P = .25)。
  • 假阴性率DBT组0.6/1000(95%CI:0.4,0.8;33/56 839)略低于DM组0.9/1000(95%CI:0.4,1.6;9/10 511),但差异无统计学意义(P = .30)。
  • 调整分析中DBT较DM的召回率、活检推荐率及召回阳性预测值均改善(P ≤ .001)。
  • DBT检出癌中浸润性癌70%(238/340)vs DM 68.5%(37/54),不良预后特征32.6%(76/233)vs 25.0%(9/36)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Limited data exist beyond prevalence rounds of digital breast tomosynthesis (DBT) screening. Purpose To compare DBT outcomes over multiple years and rounds to outcomes of digital mammography (DM) screening. Materials and Methods Retrospective analysis included 1 year of DM and 5 years of DBT screening (September 2011 to September 2016); 67 350 examinations were performed in 29 310 women. Recall rate (RR) percentage, cancer detection rate (CDR) per 1000 women screened, false-negative rate per 1000 women screened, positive predictive value of recall (PPV1) percentage, positive predictive value of biopsies performed percentage, sensitivity, and specificity were calculated. Cancers diagnosed within 1 year of screening were captured by means of linkage to state cancer registry, and biologic characteristics were grouped by prognostic factors. Performance trends across DBT rounds were compared with those from DM rounds by using logistic regression to account for examinations in the same woman. Analyses were adjusted for age, race, breast density, baseline examination, and reader. Results There were 56 839 DBT and 10 511 DM examinations. The mean patient age (± standard deviation) was 56 years ±11 for the entire cohort, 55 years ±11 for the DBT group, and 57 years ±11 for the DM group. RRs were significantly lower for the DBT group (8.0%, 4522 of 56 839; 95% confidence interval [CI]: 7.7, 8.2) than for the DM group (10.4%, 1094 of 10 511; 95% CI: 9.8, 11.0) (P < .001). CDRs were higher with DBT (6.0 per 1000 women screened; 95% CI: 5.4, 6.7 per 1000 women screened; 340 of 56 839) than with DM (5.1 per 1000 women screened; 95% CI: 3.9, 6.6 per 1000 women screened; 54 of 10 511) (P = .25), but this difference was not statistically significant. Both RR and CDR remained improved compared with DM for 5 years of DBT at the population level. False-negative rates were slightly lower for DBT (0.6 per 1000 women screened; 95% CI: 0.4, 0.8 per 1000 women screened; 33 of 56 839) than DM (0.9 per 1000 women screened; 0.4, 1.6 per 1000 women screened; nine of 10 511) overall (P = .30), but the difference was not statistically significant. In adjusted analyses, RR, biopsy recommendation rates, and PPV1 were improved for DBT versus DM (P ≤ .001). Compared with DM, a higher proportion of DBT-detected cancers were invasive (70% [238 of 340] vs 68.5% [37 of 54]) and had poor prognoses characteristics (32.6% [76 of 233] vs 25.0% [nine of 36]). Conclusion Favorable outcomes with digital breast tomosynthesis screening were sustained over multiple years and rounds. Digital breast tomosynthesis screening was associated with detection of a higher proportion of poor-prognosis cancers than was digital mammography. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Moy and Heller in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Conant EF, Zuckerman SP, McDonald ES, et al. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round. Radiology. 2020. PMID: 32154771. doi:10.1148/radiol.2020191751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。